About

A reagent supplier built around expression platforms

BOT Bioscience (百欧泰生物) researches, produces and sells bioresearch reagents from Beijing. Ten expression platforms, in-house antibody production and lot-level QC are the three things that determine whether a catalogue is useful or merely large.

The company began in 2016 as a protein expression laboratory serving academic groups that needed a protein nobody sold. That origin still shapes how we work: the catalogue exists because customers asked for specific targets, and the custom service exists because the catalogue will never cover everything.

Today the portfolio spans recombinant and native proteins, monoclonal and polyclonal antibodies, CD antigens, matched antibody pairs and small molecule reagents, with more than 10,000 proteins in stock and distribution through 50+ partners in 35 countries. Our customers are research laboratories, diagnostic kit manufacturers and biotechnology companies who need a reagent that behaves the same way in the second lot as it did in the first.

2016Founded
10+Expression platforms
35Countries served

We are deliberately not a catalogue-only business. Roughly half of our work is custom: an antibody against a target with no commercial reagent, a peptide that will not dissolve, a protein that expresses entirely into inclusion bodies. Those projects are where the expression platforms and the QC system earn their keep.

What we hold ourselves to

  • 01Data for the lot you receivePurity, activity and application data are generated on the production lot and shipped with it.
  • 02One quality standardCustom and catalogue products are released against the same criteria.
  • 03Honest feasibilityIf a target is likely to fail in the proposed platform, we say so before taking the order.
  • 04Support from the benchTechnical questions go to the scientist who made the batch.

History

How the company grew

From a single protein expression laboratory to a reagent and custom-service supplier covering 35 countries.

  1. 2016

    Founded in Beijing

    BOT Bioscience starts as a protein expression laboratory serving local academic groups.

  2. 2018

    Antibody line launched

    Polyclonal and monoclonal production capacity added, together with matched pair screening.

  3. 2020

    IVD raw material programmes

    CD antigens, small molecule haptens and diagnostic-grade proteins added for kit manufacturers.

  4. 2022

    International distribution

    Distribution agreements established across Europe, North America and Asia-Pacific.

  5. 2025

    10,000+ catalogue proteins

    Catalogue passes 10,000 proteins, supported by ten expression platforms and in-house QC.

Capabilities

Platforms and capabilities

Prokaryotic, yeast, insect, mammalian and cell-free expression are all available in house, which means the platform is chosen for the protein rather than for the production line.

  • E. coliFast, low cost, no glycosylation
  • Pichia pastorisHigh-density secretion, mannose glycans
  • Saccharomyces cerevisiaeGRAS host for food and feed targets
  • Sf9 / baculovirusInsect cell glycosylation, high yield
  • High FiveSecreted protein production
  • HEK293Human-like glycosylation for receptors
  • CHOTherapeutic-grade mammalian expression
  • NS0Stable mammalian cell lines
  • Wheat germ cell-freeMembrane proteins and toxic targets
  • Rabbit reticulocyteRapid small-scale synthesis

Release testing

Release testing
TestMethodApplied to
PuritySDS-PAGE (Coomassie / silver), RP-HPLCAll proteins and antibodies
IdentityESI-MS, peptide mappingRecombinant proteins, custom peptides
ActivityELISA, SPR, cell-based assayGrowth factors, cytokines, antibodies
EndotoxinLAL kinetic turbidimetricCell-culture grade, IVD raw material
ConcentrationA280 with extinction coefficientAll liquid formats
StabilityAccelerated and real-time, −80 °C / 4 °CCatalogue lots on stability programme

Locations

Where we are

Headquarters and production in Beijing, with commercial offices in the United States and Germany supporting distributors and direct accounts.

  • Headquarters — Beijing, China

    Building 18-D3032, Kaixuan Avenue, Liangxiang

    Fangshan District, Beijing 102400, China

  • North America — New York, USA

    Shirley, NY 11967, United States

    +1 213-335-4850

  • Europe — Frankfurt, Germany

    Gutenbergstraße 5, 59302 Kriftel

    Frankfurt am Main, Germany

    +49 919-382-3992

ContactPublications

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.